Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) General Information

Description

A 45,000 Sq. Ft. Commercial Oral Solid Dose Drug Product Manufacturing Facility Located in Irvine, United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 9601 Jeronimo Road
  • Irvine, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 9601 Jeronimo Road
  • Irvine, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Commercial Drug Product Manufacturing Facility ( 45,000 ft2 )‘s full profile, request access.

Request a free trial

Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) FAQs

  • Where is Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) headquartered?

    Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) is headquartered in Irvine, CA.

  • What industry is Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) in?

    Commercial Drug Product Manufacturing Facility ( 45,000 ft2 )’s primary industry is Buildings and Property.

  • Is Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) a private or public company?

    Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) is a Private company.

  • What is Commercial Drug Product Manufacturing Facility ( 45,000 ft2 )’s current revenue?

    The current revenue for Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) is .

  • When was Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) acquired?

    Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) was acquired on 01-Jan-2022.

  • Who acquired Commercial Drug Product Manufacturing Facility ( 45,000 ft2 )?

    Commercial Drug Product Manufacturing Facility ( 45,000 ft2 ) was acquired by BioDuro-Sundia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process